What is ACADIA Pharmaceuticals Inc.'s Shariah compliance score?

ACADIA Pharmaceuticals Inc. (ACAD) has a Shariah compliance score of 61/100 (Grade: B, Acceptable) based on AAOIFI screening standards. Scores above 70 typically indicate strong compliance. The score factors in business activity screening and financial ratio analysis including debt levels, interest-bearing deposits, and prohibited income percentages. View the full breakdown at HalalScreener.app.

Does ACADIA Pharmaceuticals Inc. pass AAOIFI screening?

ACADIA Pharmaceuticals Inc. (ACAD) partially passes with caution AAOIFI Shariah screening. AAOIFI requires: (1) no primary involvement in prohibited activities like alcohol, gambling, or conventional banking, (2) debt-to-market-cap below 30% (ACAD: 1.4%), (3) interest-bearing deposits below 30% (ACAD: 26.0%), and (4) prohibited income below 5% (ACAD: 3.2%). HalalScreener provides free AAOIFI screening for 10,000+ stocks at halalscreener.app.

How much purification is needed for ACADIA Pharmaceuticals Inc. stock?

ACADIA Pharmaceuticals Inc. (ACAD) has a non-permissible income ratio of 3.25%. Muslim investors should purify this percentage of any dividends received and capital gains realized from ACAD shares by donating it to charity. HalalScreener's purification calculator at halalscreener.app/en/purification automates this calculation using the latest financial data.

Where can I screen ACADIA Pharmaceuticals Inc. for Shariah compliance for free?

HalalScreener (halalscreener.app) offers free Shariah compliance screening for ACADIA Pharmaceuticals Inc. (ACAD) and 10,000+ other US-listed stocks, ETFs, and 100+ cryptocurrencies. The screening uses AAOIFI Standard No. 21 and shows all financial ratios transparently. No credit card or signup required for basic screening. HalalScreener also includes an AI Islamic Scholar for follow-up questions about ACAD's compliance across different madhabs (Hanafi, Shafi'i, Maliki, Hanbali, Ja'fari).

Is ACADIA Pharmaceuticals Inc. (ACAD) halal? Doubtful. Based on AAOIFI screening, ACADIA Pharmaceuticals Inc. passes the business activity screen but has financial ratios approaching AAOIFI limits with a compliance score of 61/100 (Grade: B).

ACAD: Is ACADIA Pharmaceuticals Inc. Halal?

Doubtful

ACADIA Pharmaceuticals Inc.

NASDAQHealthcareUS

$20.89

-2.93%

AvoidBorderlineClean

Purify ~3.2% of income

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psychosis, and negative symptoms of schizophrenia; Trofinetide, a novel synthetic analog, under phase 3 development for the treatment of Rett syndrome; ACP-044, a novel first-in-class orally administered non-opioid analgesic, under phase 2 development for treating acute and chronic pain; and ACP-319, a positive allosteric modulator of the muscarinic receptor, under phase 1 development for treating schizophrenia and cognition in Alzheimer's. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.

Sector: Healthcare · Industry: Biotechnology

Why This Stock Is Doubtful

Interest-bearing deposits are 26.0% of market cap, only 4.0 points below the 30% limit

Stocks are marked Doubtful when financial ratios pass but approach AAOIFI thresholds. Consider consulting a qualified scholar for a definitive ruling.

Shariah Compliance Status

AAOIFI Standard 21Updated Jun 18, 2026

Acceptable

Acceptable but room for improvement

61Score

Business Activity Screen

Passed

Checks if the business is involved in prohibited activities (alcohol, gambling, pork, conventional banking, etc.)

Financial Ratio Screen

Passed

Financial ratios must be below AAOIFI thresholds

Debt / Market Cap1.4% / 30.0%

Compliance History

Doubtfulnow
since Jun 2026
Not Halal
until the change above
Doubtful
until the change above

Tracked since May 2026. Updates automatically on each re-screen.

Screened: Jun 18, 2026Fiscal: Q1 2026Source: EDGAR

Purify Your ACAD Dividends

3.2% non-compliant income

ACAD has 3.2% prohibited income. Calculate exactly how much of your dividends to donate.

Financial Overview

Market Cap

3.6B

Price

$20.89

Sector

Healthcare

Industry

Biotechnology

More Healthcare Stocks

JNJ

Johnson & Johnson

UNH

UnitedHealth Group Incorporated

B+

ABBV

AbbVie Inc.

PFE

Pfizer Inc.

LLY

Eli Lilly and Company

A+

MRK

Merck & Co., Inc.

B+

Free · No credit card required

Track ACAD and 10,000+ stocks with AI insights

Create your free account to unlock AI-powered compliance analysis, track your portfolio, calculate purification, and get unlimited AAOIFI screening.

Get Started Free Browse Screener

10,000+ assets AAOIFI standards Free watchlist

Frequently Asked Questions

Is ACADIA Pharmaceuticals Inc. (ACAD) halal to invest in?

ACADIA Pharmaceuticals Inc. (ACAD) is rated Doubtful under AAOIFI Standard 21. It passes the business activity screen but one or more financial ratios are approaching (though not yet exceeding) the AAOIFI thresholds (30% for debt and interest deposits, 5% for prohibited income). Consult a qualified Islamic finance scholar for a personal ruling.

Why did ACADIA Pharmaceuticals Inc. get a B compliance rating?

ACADIA Pharmaceuticals Inc. (ACAD) received a grade of B (Acceptable) based on three AAOIFI Standard 21 financial ratios: debt-to-market-cap of 1.4% (limit 30%); interest-bearing deposits of 26.0% (limit 30%); prohibited income of 3.25% (limit 5%). The grade reflects the margin of safety across all three ratios relative to their thresholds.

What could change ACADIA Pharmaceuticals Inc.'s Shariah verdict?

ACADIA Pharmaceuticals Inc.'s verdict is re-evaluated at each annual re-screen. Three events could change it: (1) the debt-to-market-cap ratio crossing 30%, typically from new debt issuance or a major drop in share price; (2) interest-bearing deposits exceeding 30% of market cap; or (3) prohibited revenue (alcohol, gambling, conventional finance, etc.) exceeding 5% of total revenue. Verdict flips are tracked in the compliance history section above.

How often is ACADIA Pharmaceuticals Inc. re-screened for Shariah compliance?

ACADIA Pharmaceuticals Inc. (ACAD) is re-screened annually using the most recent full-year financial data from SEC filings. HalalScreener also triggers an on-demand re-screen whenever the stored data is more than 7 days old, ensuring the ratios reflect the latest available financial statements. Last screened: Jun 18, 2026.

Screened according to AAOIFI Standard No. 21 · For informational purposes only. Consult a qualified Islamic finance advisor before investing.

Disclaimer: This screening is for informational purposes only and does not constitute financial, legal, or religious advice. Compliance is evaluated using AAOIFI financial standards (debt, deposits, and prohibited income ratios) and publicly available data. Ethical, political, social, or environmental considerations are outside the scope of this screening. Individual scholars and methodologies may differ. Always consult a qualified Islamic finance advisor before making investment decisions.